Dr. Daniel S. Bradford, MD

Dr. Bradford practices at Mercy Hospital Northwest Arkansas in Rogers, Arkansas, part of Mercy.

Dr. Bradford's NPI, 1033180229, was assigned on January 27, 2006. Dr. Bradford graduated from University of Arkansas For Medical Sciences College of Medicine in 1983. Dr. Bradford holds Arkansas license C6376.

Dr. Bradford's primary practice is Mercy Hospital Northwest Arkansas, at 2710 South Rife Medical Lane, Rogers, AR 72758 in Benton County. The practice phone is (479) 338-8000.

Dr. Bradford's primary practice is Mercy Hospital Northwest Arkansas in Rogers, Arkansas, part of Mercy. The medical group on file is Highlands Oncology Group. Dmand AI also links Dr. Bradford to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bradford practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bradford's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bradford is licensed in Arkansas.

Dmand AI lists ankle or foot injury, arthritis, asthma, chronic anemia, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic skin ulcer and circulatory problems in extremities among the conditions Dr. Bradford treats.

CMS data shows 3,253 Medicare services from Dr. Bradford across 22 procedure codes in 2024, for 85 Medicare patients. Medicare paid $33,443 for them. Every service was in an office.

CMS counts 85 Medicare patients who saw Dr. Bradford in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bradford's median patient age at 70, with 51% women.

In 2024, Dr. Bradford wrote 183 Medicare Part D claims for 82 patients. 79% of them were for generic drugs. CMS names the drug for 104 of them, across 5 drugs with 11 or more claims each, at $2,216 in total drug cost. In 2023, CMS named 965 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bradford for performance year 2024, reported as part of a group.

Dmand AI links 6 papers to Dr. Bradford, published from 2010 to 2023. The most frequent topics are Lung Neoplasms. Dr. Bradford's most frequent co-authors are Mark A. Socinski, MD, Jeffrey M. Crane, MD and Thomas A. Hensing, MD.

Dmand AI links Dr. Bradford to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 347 general payments to Dr. Bradford from 54 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,140.

Dmand AI lists 1 award for Dr. Bradford, most recently CMS Stage 1 EHR in 2012.

Dr. Bradford graduated from University of Arkansas For Medical Sciences College of Medicine in 1983. Dr. Bradford is a member of ASCO.

Dr. Bradford is in network with 2 carriers, including Cigna and AR State Medicaid. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.